DermEffects - Probity - PPDS

London, Ontario N6H 5L5

0 studies enrolling now · 3 studies all time

What they study most

Hidradenitis Suppurativa, Plaque Psoriasis

Studies at this site

• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis — Completed